Missouri is on the brink of changing how it funds and provides naloxone to first-responders.
The program is credited for reducing overdoses, but it faces a potential budget cut of $8 million.
Rachel Winograd discusses the origins, successes and uncertain future of naloxone in Missouri. Winograd is a
@umsl professor and director of addiction science at the Missouri Institute for Mental Health. Her team is responsible for distributing naloxone for the entire state.
“We got our first funding for naloxone in 2017, and that year we gave out about 1,100 naloxone kits,” she said. “Last year, we distributed over 650,000 naloxone kits across the state. That has been a huge amount of growth.”
Lawmakers continue to debate the final budget before the legislative session ends next month. Last week, the Senate Appropriations Committee discussed restoring $5 million for naloxone funding, the Missouri Independent reported.
However, that proposal comes with a requirement that the state purchase Narcan, the more expensive, brand name version of naloxone. Winograd called the committee’s proposal “scandalous.”
“[Narcan] is more than a $7 difference per box,” she said. “You multiply that by hundreds of thousands of boxes, [and] we are talking about losing out on almost 100,000 doses of naloxone.”
Hear he full
@stlonair episode via the link in bio or wherever you get your podcasts.
✍️: Danny Wicentowski
📸: Brian Munoz |
@brianmmunoz